CSLLY
Price
$85.40
Change
-$1.05 (-1.21%)
Updated
Aug 8 closing price
Capitalization
82.1B
VIR
Price
$4.30
Change
-$0.05 (-1.15%)
Updated
Aug 8 closing price
Capitalization
597.34M
82 days until earnings call
Interact to see
Advertisement

CSLLY vs VIR

Header iconCSLLY vs VIR Comparison
Open Charts CSLLY vs VIRBanner chart's image
CSL
Price$85.40
Change-$1.05 (-1.21%)
Volume$24.59K
Capitalization82.1B
Vir Biotechnology
Price$4.30
Change-$0.05 (-1.15%)
Volume$1.54M
Capitalization597.34M
CSLLY vs VIR Comparison Chart in %
Loading...
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSLLY vs. VIR commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSLLY is a Hold and VIR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 10, 2025
Stock price -- (CSLLY: $85.40 vs. VIR: $4.30)
Brand notoriety: CSLLY and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSLLY: 39% vs. VIR: 138%
Market capitalization -- CSLLY: $82.1B vs. VIR: $597.34M
CSLLY [@Biotechnology] is valued at $82.1B. VIR’s [@Biotechnology] market capitalization is $597.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSLLY’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • CSLLY’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, CSLLY is a better buy in the long-term than VIR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSLLY’s TA Score shows that 3 TA indicator(s) are bullish while VIR’s TA Score has 4 bullish TA indicator(s).

  • CSLLY’s TA Score: 3 bullish, 6 bearish.
  • VIR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, VIR is a better buy in the short-term than CSLLY.

Price Growth

CSLLY (@Biotechnology) experienced а +0.35% price change this week, while VIR (@Biotechnology) price change was -14.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.25%. For the same industry, the average monthly price growth was +6.85%, and the average quarterly price growth was +13.24%.

Reported Earning Dates

VIR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+0.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSLLY($82.1B) has a higher market cap than VIR($597M). CSLLY YTD gains are higher at: -1.662 vs. VIR (-41.417). CSLLY has higher annual earnings (EBITDA): 4.73B vs. VIR (-598.69M). CSLLY has more cash in the bank: 1.52B vs. VIR (802M). VIR has less debt than CSLLY: VIR (96.1M) vs CSLLY (12B). CSLLY has higher revenues than VIR: CSLLY (14.7B) vs VIR (14.3M).
CSLLYVIRCSLLY / VIR
Capitalization82.1B597M13,752%
EBITDA4.73B-598.69M-791%
Gain YTD-1.662-41.4174%
P/E Ratio31.34N/A-
Revenue14.7B14.3M102,797%
Total Cash1.52B802M190%
Total Debt12B96.1M12,487%
FUNDAMENTALS RATINGS
CSLLY vs VIR: Fundamental Ratings
CSLLY
VIR
OUTLOOK RATING
1..100
7357
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5397
PRICE GROWTH RATING
1..100
5191
P/E GROWTH RATING
1..100
7829
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSLLY's Valuation (2) in the null industry is somewhat better than the same rating for VIR (39). This means that CSLLY’s stock grew somewhat faster than VIR’s over the last 12 months.

CSLLY's Profit vs Risk Rating (100) in the null industry is in the same range as VIR (100). This means that CSLLY’s stock grew similarly to VIR’s over the last 12 months.

CSLLY's SMR Rating (53) in the null industry is somewhat better than the same rating for VIR (97). This means that CSLLY’s stock grew somewhat faster than VIR’s over the last 12 months.

CSLLY's Price Growth Rating (51) in the null industry is somewhat better than the same rating for VIR (91). This means that CSLLY’s stock grew somewhat faster than VIR’s over the last 12 months.

VIR's P/E Growth Rating (29) in the null industry is somewhat better than the same rating for CSLLY (78). This means that VIR’s stock grew somewhat faster than CSLLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSLLYVIR
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 17 days ago
52%
Bullish Trend 5 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRNC9.160.58
+6.76%
Cerence
CFBK23.970.20
+0.84%
CF Bankshares
WBA11.940.04
+0.34%
Walgreens Boots Alliance
KYMR40.62-0.23
-0.56%
Kymera Therapeutics
TKLF3.71-0.19
-4.87%
Tokyo Lifestyle Co Ltd

CSLLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSLLY has been loosely correlated with ADPT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CSLLY jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSLLY
1D Price
Change %
CSLLY100%
-1.21%
ADPT - CSLLY
34%
Loosely correlated
-2.71%
RXRX - CSLLY
34%
Loosely correlated
-0.92%
VIR - CSLLY
33%
Poorly correlated
-1.15%
FOLD - CSLLY
33%
Poorly correlated
-0.44%
CDXS - CSLLY
33%
Poorly correlated
-0.36%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with SANA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-1.15%
SANA - VIR
64%
Loosely correlated
+1.01%
AXON - VIR
47%
Loosely correlated
-3.27%
CPRX - VIR
45%
Loosely correlated
+1.15%
NRIX - VIR
41%
Loosely correlated
-2.28%
CMPX - VIR
40%
Loosely correlated
-7.22%
More